Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05690321

Opium Tincture Against Chronic Diarrhea - Patients

Conditions: Chronic Diarrhea

Sex: All
Ages: 20 Years – N/A
Phase: PHASE2
Enrollment: 16
Sponsor: Asbjørn Mohr Drewes

Location: Denmark

Summary

The purpose of this study is to investigate the mechanistic anti-propulsive effects of opium tincture on the gastrointestinal tract of a cohort of patients with chronic diarrhea

Eligibility Criteria

Inclusion Criteria:• Signed informed consent before any study specific proceduresAble to read and understand DanishMale or female with an age of 20 years or moreThe researcher believes that the participant understands what the study entails, are capable of following instructions, can attend when needed, and are expected to complete the study.The investigator will ensure that fertile female participants have a negative pregnancy test before each treatment visit and use contraception during the entity of the study.Specific underlying pathophysiology has been identified, but targeted treatment (e.g. antibiotics or bile acid sequestrants) and treatment with loperamide has failed.ORNo specific underlying pathophysiology has been identified and treatment with loperamide has failed.At least 6 months post-surgery in the gastrointestinal tractNo sign of cancer at standard clinical follow-upChronic diarrhea defined as at least 3 daily bowel movements for the last weekExclusion Criteria:• Known allergy towards pharmaceutical compounds similar to Dropizol.Participation in other studies within 14 days of first visit (1 year if opioids involved).Expected need of medical/surgical treatment during the studyHistory of psychiatric illness (e.g. mental retardation, schizophrenia, major depression)History of substance abuse (e.g. alcohol, THC, benzodiazepine, central stimulants and/or opioids)Family history of substance abuseKnown major stenosis of the intestinesKnown severe decreased renal function (defined as eGFR below 30)Known severe decreased hepatic function (defined as Child-Pugh class B or higher)Treatment with MAO- inhibitors during the entity of the studySevere COPD or acute severe asthma (defined as FEV1 below 50 % or acute ongoing exacerbation)Known cor pulmonaleFemale participants that are lactatingMedicine known to affect gastrointestinal motility must not be initiated during the entity of the studyTreatment with opium tincture during the last month

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05690321). StuddyBuddy aggregates publicly available trial information.